Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $1.03B (100.0% shares, 0.0% debt)

Holdings (34)

— SPRINGWORKS THERAPEUTICS INC 26.5%

Value $273M Shares 4,831,307 Est. Cost $21.68 Unrealized —

— DYNAVAX TECHNOLOGIES CORP 8.9%

Value $91.22M Shares 8,415,000 Est. Cost $9.83 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 7.4%

Value $76.64M Shares 3,979,292 Est. Cost $26.87 Unrealized -37.0%

PHVS PHARVARIS N V 5.6%

Value $57.68M Shares 3,180,601 Est. Cost $31.46 Unrealized -44.1%

RPID RAPID MICRO BIOSYSTEMS INC 5.6%

Value $57.27M Shares 8,434,560 Est. Cost $20.66 Unrealized -64.4%

NUVL NUVALENT INC 4.6%

Value $47.62M Shares 3,428,014 Est. Cost $29.01 Unrealized -49.9%

CRNX CRINETICS PHARMACEUTICALS IN 4.3%

Value $44.55M Shares 2,029,701 Est. Cost $18.52 Unrealized +9.3%

— EQRX INC 4.0%

Value $41.31M Shares 10,003,573 Est. Cost $6.82 Unrealized —

CCCC C4 THERAPEUTICS INC 3.9%

Value $39.84M Shares 1,642,210 Est. Cost $29.00 Unrealized -16.3%

AMLX AMYLYX PHARMACEUTICALS INC 3.4%

Value $35.41M Shares 2,756,050 Est. Cost $22.45 Unrealized 0.0%

— MERSANA THERAPEUTICS INC 2.5%

Value $26.02M Shares 6,522,030 Est. Cost $15.29 Unrealized —

— 2SEVENTY BIO INC 2.3%

Value $24.04M Shares 1,408,901 Est. Cost $18.15 Unrealized —

— APTINYX INC 2.0%

Value $20.18M Shares 8,891,758 Est. Cost $8.16 Unrealized —

XLO XILIO THERAPEUTICS INC 1.9%

Value $19.83M Shares 2,805,413 Est. Cost $17.03 Unrealized -33.7%

NRIX NURIX THERAPEUTICS INC 1.7%

Value $17.99M Shares 1,284,313 Est. Cost $25.20 Unrealized -29.6%

AVIR ATEA PHARMACEUTICALS INC 1.7%

Value $17.95M Shares 2,485,638 Est. Cost $32.23 Unrealized -78.9%

SVRA SAVARA INC 1.5%

Value $15.23M Shares 11,622,598 Est. Cost $1.49 Unrealized -19.0%

TNGX TANGO THERAPEUTICS INC 1.4%

Value $14.57M Shares 1,921,790 Est. Cost $11.99 Unrealized -27.7%

— MARINUS PHARMACEUTICALS INC 1.3%

Value $13.38M Shares 1,431,058 Est. Cost $15.48 Unrealized —

— RESEARCH ALLIANCE CORP II 0.9%

Value $9.76M Shares 1,000,000 Est. Cost $10.25 Unrealized —

— SOLID BIOSCIENCES INC 0.9%

Value $9.516M Shares 7,929,918 Est. Cost $7.99 Unrealized —

ANNX ANNEXON INC 0.9%

Value $8.85M Shares 3,241,628 Est. Cost $23.46 Unrealized -73.8%

IVVD ADAGIO THERAPEUTICS INC 0.9%

Value $8.834M Shares 1,937,207 Est. Cost $37.11 Unrealized -83.5%

NAUT NAUTILUS BIOTECHNOLOGY INC 0.8%

Value $8.68M Shares 2,000,000 Est. Cost $10.83 Unrealized -62.1%

— SYROS PHARMACEUTICALS INC 0.7%

Value $7.455M Shares 6,264,420 Est. Cost $10.27 Unrealized —

— ARYA SCIENCES ACQU CORP IV 0.7%

Value $6.86M Shares 700,000 Est. Cost $10.47 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 0.6%

Value $6.55M Shares 2,847,689 Est. Cost $9.18 Unrealized —

— X4 PHARMACEUTICALS INC 0.5%

Value $5.284M Shares 3,019,540 Est. Cost $7.84 Unrealized —

— PANACEA ACQUISITION CORP II 0.5%

Value $4.875M Shares 500,000 Est. Cost $10.02 Unrealized —

— ARYA SCIENCES ACQUISITN CORP 0.5%

Value $4.855M Shares 500,000 Est. Cost $9.88 Unrealized —

— BCLS ACQUISITION CORP 0.5%

Value $4.812M Shares 487,500 Est. Cost $11.14 Unrealized —

— OMEGA ALPHA SPAC 0.4%

Value $3.928M Shares 400,000 Est. Cost $9.90 Unrealized —

— FRAZIER LIFESCIENCES ACQU CO 0.3%

Value $2.997M Shares 300,000 Est. Cost $10.38 Unrealized —

— JIYA ACQUISITION CORP 0.3%

Value $2.949M Shares 300,000 Est. Cost $10.30 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	4,831,307	$273M	26.5%	$21.68	—	COM	85205L107
—	DYNAVAX TECHNOLOGIES CORP	8,415,000	$91.22M	8.9%	$9.83	—	COM NEW	268158201
ARQT	ARCUTIS BIOTHERAPEUTICS INC	3,979,292	$76.64M	7.4%	$26.87	-37.0%	COM	03969K108
PHVS	PHARVARIS N V	3,180,601	$57.68M	5.6%	$31.46	-44.1%	COM	N69605108
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$57.27M	5.6%	$20.66	-64.4%	CLASS A COM	75340L104
NUVL	NUVALENT INC	3,428,014	$47.62M	4.6%	$29.01	-49.9%	COM	670703107
CRNX	CRINETICS PHARMACEUTICALS IN	2,029,701	$44.55M	4.3%	$18.52	+9.3%	COM	22663K107
—	EQRX INC	10,003,573	$41.31M	4.0%	$6.82	—	COM	26886C107
CCCC	C4 THERAPEUTICS INC	1,642,210	$39.84M	3.9%	$29.00	-16.3%	COM STK	12529R107
AMLX	AMYLYX PHARMACEUTICALS INC	2,756,050	$35.41M	3.4%	$22.45	0.0%	COM	03237H101
—	MERSANA THERAPEUTICS INC	6,522,030	$26.02M	2.5%	$15.29	—	COM	59045L106
—	2SEVENTY BIO INC	1,408,901	$24.04M	2.3%	$18.15	—	COMMON STOCK	901384107
—	APTINYX INC	8,891,758	$20.18M	2.0%	$8.16	—	COM	03836N103
XLO	XILIO THERAPEUTICS INC	2,805,413	$19.83M	1.9%	$17.03	-33.7%	COM	98422T100
NRIX	NURIX THERAPEUTICS INC	1,284,313	$17.99M	1.7%	$25.20	-29.6%	COM	67080M103
AVIR	ATEA PHARMACEUTICALS INC	2,485,638	$17.95M	1.7%	$32.23	-78.9%	COM	04683R106
SVRA	SAVARA INC	11,622,598	$15.23M	1.5%	$1.49	-19.0%	COM	805111101
TNGX	TANGO THERAPEUTICS INC	1,921,790	$14.57M	1.4%	$11.99	-27.7%	COM	87583X109
—	MARINUS PHARMACEUTICALS INC	1,431,058	$13.38M	1.3%	$15.48	—	COM NEW	56854Q200
—	RESEARCH ALLIANCE CORP II	1,000,000	$9.76M	0.9%	$10.25	—	COM CL A	760873109
—	SOLID BIOSCIENCES INC	7,929,918	$9.516M	0.9%	$7.99	—	COM	83422E105
ANNX	ANNEXON INC	3,241,628	$8.85M	0.9%	$23.46	-73.8%	COM	03589W102
IVVD	ADAGIO THERAPEUTICS INC	1,937,207	$8.834M	0.9%	$37.11	-83.5%	COM	00534A102
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$8.68M	0.8%	$10.83	-62.1%	COM	63909J108
—	SYROS PHARMACEUTICALS INC	6,264,420	$7.455M	0.7%	$10.27	—	COM	87184Q107
—	ARYA SCIENCES ACQU CORP IV	700,000	$6.86M	0.7%	$10.47	—	CL A	G31659108
—	AEGLEA BIOTHERAPEUTICS INC	2,847,689	$6.55M	0.6%	$9.18	—	COM	00773J103
—	X4 PHARMACEUTICALS INC	3,019,540	$5.284M	0.5%	$7.84	—	COM	98420X103
—	PANACEA ACQUISITION CORP II	500,000	$4.875M	0.5%	$10.02	—	CL A SHS	G6882C106
—	ARYA SCIENCES ACQUISITN CORP	500,000	$4.855M	0.5%	$9.88	—	CLASS A ORD SHS	G31658100
—	BCLS ACQUISITION CORP	487,500	$4.812M	0.5%	$11.14	—	COM CL A	G0904B105
—	OMEGA ALPHA SPAC	400,000	$3.928M	0.4%	$9.90	—	CL A	G6749V107
—	FRAZIER LIFESCIENCES ACQU CO	300,000	$2.997M	0.3%	$10.38	—	UNIT 12/09/2025	G3710A121
—	JIYA ACQUISITION CORP	300,000	$2.949M	0.3%	$10.30	—	COM CL A	47760M102